Cargando…
Anatomical liver resection improves surgical outcomes for combined hepatocellular-cholangiocarcinoma: A propensity score matched study
BACKGROUND: The efficacies of anatomical resection (AR) and non-anatomical resection (NAR) in the treatment of combined hepatocellular-cholangiocarcinoma (cHCC-CCA) remain unclear. This study aimed to compare the prognostic outcomes of AR with those of NAR for cHCC-CCA. METHOD: Patients diagnosed wi...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9433922/ https://www.ncbi.nlm.nih.gov/pubmed/36059669 http://dx.doi.org/10.3389/fonc.2022.980736 |
_version_ | 1784780742396477440 |
---|---|
author | Wang, Wen-qiang Li, Jian Liang, Bin-yong Lv, Xing Zhu, Rong-hua Wang, Jin-lin Huang, Zhi-yong Yang, Shu-hong Zhang, Er-lei |
author_facet | Wang, Wen-qiang Li, Jian Liang, Bin-yong Lv, Xing Zhu, Rong-hua Wang, Jin-lin Huang, Zhi-yong Yang, Shu-hong Zhang, Er-lei |
author_sort | Wang, Wen-qiang |
collection | PubMed |
description | BACKGROUND: The efficacies of anatomical resection (AR) and non-anatomical resection (NAR) in the treatment of combined hepatocellular-cholangiocarcinoma (cHCC-CCA) remain unclear. This study aimed to compare the prognostic outcomes of AR with those of NAR for cHCC-CCA. METHOD: Patients diagnosed with pathology-confirmed cHCC-CCA, and who underwent curative resection at Tongji hospital between January 2010 and December 2019 were included in this retrospective study. A one-to-one propensity score matching (PSM) analysis was used to compare the long-term outcomes of AR to those of NAR. RESULTS: A total of 105 patients were analyzed, of whom 48 (45.7%) and 57 (54.3%) underwent AR and NAR, respectively. There were no significant differences in short-term outcomes between the two groups, including duration of postoperative hospital stay, the incidence of perioperative complications, and incidence of 30-day mortality. However, both, the 5-year overall survival (OS) and recurrence-free survival (RFS) rates of AR were significantly better than those of NAR (40.5% vs. 22.4%, P=0.002; and 37.3% vs. 14.4%, P=0.002, respectively). Multivariate analysis showed that NAR, multiple tumors, larger-sized tumors (>5 cm), cirrhosis, lymph node metastasis, and vascular invasion were independent risk factors for poor prognoses. Stratified analysis demonstrated similar outcomes following AR versus NAR for patients with tumors > 5cm in diameter, while AR had better survival than NAR in patients with tumors ≤5 cm in diameter. After PSM, when 34 patients from each group were matched, the 5-year OS and RFS rates of AR were still better than those of NAR. CONCLUSION: Patients with cHCC-CCA who underwent AR had better long-term surgical outcomes than those who underwent NAR, especially for those with tumors ≤5 cm in diameter. However, no differences in the risk of surgical complications were detected between the two groups. |
format | Online Article Text |
id | pubmed-9433922 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-94339222022-09-02 Anatomical liver resection improves surgical outcomes for combined hepatocellular-cholangiocarcinoma: A propensity score matched study Wang, Wen-qiang Li, Jian Liang, Bin-yong Lv, Xing Zhu, Rong-hua Wang, Jin-lin Huang, Zhi-yong Yang, Shu-hong Zhang, Er-lei Front Oncol Oncology BACKGROUND: The efficacies of anatomical resection (AR) and non-anatomical resection (NAR) in the treatment of combined hepatocellular-cholangiocarcinoma (cHCC-CCA) remain unclear. This study aimed to compare the prognostic outcomes of AR with those of NAR for cHCC-CCA. METHOD: Patients diagnosed with pathology-confirmed cHCC-CCA, and who underwent curative resection at Tongji hospital between January 2010 and December 2019 were included in this retrospective study. A one-to-one propensity score matching (PSM) analysis was used to compare the long-term outcomes of AR to those of NAR. RESULTS: A total of 105 patients were analyzed, of whom 48 (45.7%) and 57 (54.3%) underwent AR and NAR, respectively. There were no significant differences in short-term outcomes between the two groups, including duration of postoperative hospital stay, the incidence of perioperative complications, and incidence of 30-day mortality. However, both, the 5-year overall survival (OS) and recurrence-free survival (RFS) rates of AR were significantly better than those of NAR (40.5% vs. 22.4%, P=0.002; and 37.3% vs. 14.4%, P=0.002, respectively). Multivariate analysis showed that NAR, multiple tumors, larger-sized tumors (>5 cm), cirrhosis, lymph node metastasis, and vascular invasion were independent risk factors for poor prognoses. Stratified analysis demonstrated similar outcomes following AR versus NAR for patients with tumors > 5cm in diameter, while AR had better survival than NAR in patients with tumors ≤5 cm in diameter. After PSM, when 34 patients from each group were matched, the 5-year OS and RFS rates of AR were still better than those of NAR. CONCLUSION: Patients with cHCC-CCA who underwent AR had better long-term surgical outcomes than those who underwent NAR, especially for those with tumors ≤5 cm in diameter. However, no differences in the risk of surgical complications were detected between the two groups. Frontiers Media S.A. 2022-08-18 /pmc/articles/PMC9433922/ /pubmed/36059669 http://dx.doi.org/10.3389/fonc.2022.980736 Text en Copyright © 2022 Wang, Li, Liang, Lv, Zhu, Wang, Huang, Yang and Zhang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Wang, Wen-qiang Li, Jian Liang, Bin-yong Lv, Xing Zhu, Rong-hua Wang, Jin-lin Huang, Zhi-yong Yang, Shu-hong Zhang, Er-lei Anatomical liver resection improves surgical outcomes for combined hepatocellular-cholangiocarcinoma: A propensity score matched study |
title | Anatomical liver resection improves surgical outcomes for combined hepatocellular-cholangiocarcinoma: A propensity score matched study |
title_full | Anatomical liver resection improves surgical outcomes for combined hepatocellular-cholangiocarcinoma: A propensity score matched study |
title_fullStr | Anatomical liver resection improves surgical outcomes for combined hepatocellular-cholangiocarcinoma: A propensity score matched study |
title_full_unstemmed | Anatomical liver resection improves surgical outcomes for combined hepatocellular-cholangiocarcinoma: A propensity score matched study |
title_short | Anatomical liver resection improves surgical outcomes for combined hepatocellular-cholangiocarcinoma: A propensity score matched study |
title_sort | anatomical liver resection improves surgical outcomes for combined hepatocellular-cholangiocarcinoma: a propensity score matched study |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9433922/ https://www.ncbi.nlm.nih.gov/pubmed/36059669 http://dx.doi.org/10.3389/fonc.2022.980736 |
work_keys_str_mv | AT wangwenqiang anatomicalliverresectionimprovessurgicaloutcomesforcombinedhepatocellularcholangiocarcinomaapropensityscorematchedstudy AT lijian anatomicalliverresectionimprovessurgicaloutcomesforcombinedhepatocellularcholangiocarcinomaapropensityscorematchedstudy AT liangbinyong anatomicalliverresectionimprovessurgicaloutcomesforcombinedhepatocellularcholangiocarcinomaapropensityscorematchedstudy AT lvxing anatomicalliverresectionimprovessurgicaloutcomesforcombinedhepatocellularcholangiocarcinomaapropensityscorematchedstudy AT zhuronghua anatomicalliverresectionimprovessurgicaloutcomesforcombinedhepatocellularcholangiocarcinomaapropensityscorematchedstudy AT wangjinlin anatomicalliverresectionimprovessurgicaloutcomesforcombinedhepatocellularcholangiocarcinomaapropensityscorematchedstudy AT huangzhiyong anatomicalliverresectionimprovessurgicaloutcomesforcombinedhepatocellularcholangiocarcinomaapropensityscorematchedstudy AT yangshuhong anatomicalliverresectionimprovessurgicaloutcomesforcombinedhepatocellularcholangiocarcinomaapropensityscorematchedstudy AT zhangerlei anatomicalliverresectionimprovessurgicaloutcomesforcombinedhepatocellularcholangiocarcinomaapropensityscorematchedstudy |